Cargando…
The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma
SIMPLE SUMMARY: The important role of relative dose intensity (RDI) of first-line chemotherapy in improving the prognosis of diffuse large B-cell lymphoma has been widely known, but no studies have focused on the trajectory of the average RDI (ARDI) during cycles. We explored the patterns of changes...
Autores principales: | Lee, Shin, Fujita, Kei, Morishita, Tetsuji, Negoro, Eiju, Tsukasaki, Hikaru, Oiwa, Kana, Hara, Takeshi, Tsurumi, Hisashi, Ueda, Takanori, Yamauchi, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526837/ https://www.ncbi.nlm.nih.gov/pubmed/37760427 http://dx.doi.org/10.3390/cancers15184458 |
Ejemplares similares
-
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma
por: Oiwa, Kana, et al.
Publicado: (2023) -
Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis
por: Oiwa, K., et al.
Publicado: (2021) -
Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018) -
Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis
por: YAMAUCHI, TAKAHIRO, et al.
Publicado: (2015) -
3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis
por: Araie, Hiroaki, et al.
Publicado: (2017)